Wegovy Study Bolsters Use In Patients With Obesity and Heart Disease

Weight-Loss Drugs Among the Most Sought-After New Corporate Benefits

Novo to Build $6 Billion Plant as Obesity Drug Demand Surges

An Opioid-Like Drink Is Masquerading As a Wholesome Alcohol Alternative

Novavax Unveils Plan to Cut Costs by Another $300 Million

Astra Enters Obesity Drug Race With Chinese Biotech Deal

Merck KGaA Beats on Earnings Amid Demand for Cancer Drugs

China Healthcare Stocks On Recovery Path After $142 Billion Rout

New Ozempic Rival Is About to Make Your Weight Loss Drugs Cheaper

Eli Lilly Wins FDA Nod for Obesity Drug That Rivals Wegovy, Ozempic

Israel’s Teva Lifts Outlook With War Not Curbing Drug Production

Xi to Meet US Business Leaders for Dinner in San Francisco